MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14744/hf.2026.44190

Медицинская библиотека · Hepatology forum · 2026

TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Yilmaz Yusuf, Adali Gupse, Ergenc Ilkay, Kaya Eda, Gokce Dilara Turan, Keklikkiran Caglayan, Zeybel Mujdat, Us Gediz Dogay, Degertekin Bulent, Idilman Ramazan, Turkish Association for the Study of the Liver (TASL) Obesity Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Special Interest Group (SIG), Akarca Ulus Salih, Karasu Zeki, Kaymakoglu Sabahattin, Tozun Nurdan, Uygun Ahmet

СтатьяПеревод пока не подготовлен

Аннотация

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and represents a major and growing public health challenge in Türkiye. This guidance provides an updated, clinically oriented overview of the definition, epidemiology, screening, diagnosis, risk stratification, and management of MASLD, with particular emphasis on evolving nomenclature, non-invasive diagnostic pathways, and current treatment strategies. The document addresses the full clinical spectrum of disease, from steatosis and metabolic dysfunction-associated steatohepatitis (MASH) to advanced fibrosis, cirrhosis, hepatocellular carcinoma, and liver transplantation. The guidance also incorporates evidence and practice considerations relevant to the Turkish population, including local epidemiology, resource availability, and implementation challenges in real-world care. Finally, areas of uncertainty and evidence gaps are highlighted to support future research and locally relevant policy development.

Для цитирования: Yilmaz Yusuf, Adali Gupse, Ergenc Ilkay, Kaya Eda, Gokce Dilara Turan, Keklikkiran Caglayan, Zeybel Mujdat, Us Gediz Dogay, Degertekin Bulent, Idilman Ramazan, Turkish Association for the Study of the Liver (TASL) Obesity Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Special Interest Group (SIG), Akarca Ulus Salih, Karasu Zeki, Kaymakoglu Sabahattin, Tozun Nurdan, Uygun Ahmet. TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD).. Hepatology forum. 2026. DOI: 10.14744/hf.2026.44190.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.